πŸ‡ΊπŸ‡Έ FDA
Patent

US 12091411

IRAK degraders and uses thereof

granted A61KA61K45/06A61K47/55

Quick answer

US patent 12091411 (IRAK degraders and uses thereof) held by Kymera Therapeutics, Inc. expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Kymera Therapeutics, Inc.
Grant date
Tue Sep 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K45/06, A61K47/55